Formative Research for the Development of Evidence-Based Targeted Water, Sanitation, and Hygiene Interventions to Reduce Cholera in Hotspots in the Democratic Republic of the Congo: Preventative Intervention for Cholera for 7 Days (PICHA7) Program.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
27 09 2022
Historique:
received: 18 07 2022
revised: 18 08 2022
accepted: 05 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Compared to the general public, household members of cholera patients are at a 100 times higher risk of contracting cholera during the 7-day high-risk period after a cholera patient has been admitted to a health facility for treatment. The Preventative-Intervention-for-Cholera-for-7-days (PICHA7) program aims to reduce household transmission of cholera during this 7-day high-risk period through a health facility-initiated water, sanitation, and hygiene (WASH) program promoting handwashing with soap, water treatment, and safe water storage. The PICHA7 program is delivered to cholera patient households through: (1) a pictorial flipbook delivered by a health promoter; (2) a cholera prevention package (handwashing station, drinking water vessel with lid and tap, and chlorine tablets); and (3) weekly WASH mobile messages sent to patient households in the Democratic Republic of the Congo (DRC). The objectives of this study were to conduct formative research to identify facilitators and barriers of the promoted WASH behaviors for cholera patient households and to tailor the PICHA7 program to target these facilitators and barriers. Formative research included 93 semi-structured interviews with diarrhea patient households and healthcare workers during exploratory research and a pilot study of 518 participants. Barriers to the promoted WASH behaviors identified during exploratory and pilot study interviews included: (1) low awareness of cholera transmission and prevention; (2) unaffordability of soap for handwashing; and (3) intermittent access to water limiting water for handwashing. For intervention development, narratives of the lived experiences of patient households in our study were presented by health promoters to describe cholera transmission and prevention, and soapy water and ash were promoted in the program flipbook and mobile messages to address the affordability of soap for handwashing. A jerry can was provided to allow for additional water storage, and a tap with a slower flow rate was attached to the handwashing station to reduce the amount of water required for handwashing. The pilot findings indicate that the PICHA7 program has high user acceptability and is feasible to deliver to cholera patients that present at health facilities for treatment in our study setting. Formative research allowed for tailoring this targeted WASH program for cholera patient households in the DRC.

Identifiants

pubmed: 36231546
pii: ijerph191912243
doi: 10.3390/ijerph191912243
pmc: PMC9566157
pii:
doi:

Substances chimiques

Drinking Water 0
Soaps 0
Chlorine 4R7X1O2820

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Foreign and Commonwealth Office
ID : 215674/Z/19/Z

Références

BMC Infect Dis. 2010 Nov 26;10:339
pubmed: 21110853
Bull World Health Organ. 1986;64(1):127-31
pubmed: 3488134
BMC Public Health. 2021 Mar 1;21(1):427
pubmed: 33648466
Int J Environ Res Public Health. 2022 Sep 27;19(19):
pubmed: 36231546
Lancet. 2017 Sep 23;390(10101):1539-1549
pubmed: 28302312
Emerg Infect Dis. 2015 Nov;21(11):2006-13
pubmed: 26484778
J Pain Symptom Manage. 2019 Oct;58(4):696-706
pubmed: 31216430
Trop Med Int Health. 2020 Aug;25(8):996-1007
pubmed: 32406989
BMJ Open. 2020 Jan 26;10(1):e031568
pubmed: 31988222
PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832
pubmed: 26043000
Int J Epidemiol. 1993 Apr;22(2):327-33
pubmed: 8505192
Nicotine Tob Res. 2014 Jan;16(1):42-9
pubmed: 23892826
Health Educ Behav. 2017 Aug;44(4):613-625
pubmed: 28071141
BMC Public Health. 2013 Oct 26;13:1015
pubmed: 24160869
J Health Commun. 2020;25(1):54-65
pubmed: 31829829
BMC Public Health. 2013 Sep 23;13:877
pubmed: 24060247
J Infect Dis. 2018 Aug 24;218(7):1164-1168
pubmed: 29757428
Psychol Health. 2010 Dec;25(10):1161-74
pubmed: 20204973
J Health Popul Nutr. 2016 Feb 09;35:3
pubmed: 26858019
J Commun. 2012 Jun 1;62(3):473-492
pubmed: 22736808
BMC Public Health. 2019 Jul 31;19(1):1028
pubmed: 31366398
BMJ Open. 2021 Oct 14;11(10):e050943
pubmed: 34649847
Emerg Infect Dis. 2008 May;14(5):798-800
pubmed: 18439365
J Infect Dis. 2013 Nov 1;208 Suppl 1:S86-91
pubmed: 24101651
BMC Public Health. 2013 Jan 22;13:60
pubmed: 23339647
BMC Public Health. 2013 Mar 19;13:242
pubmed: 23509860
Lancet. 2018 May 12;391(10133):1908-1915
pubmed: 29502905
Am J Trop Med Hyg. 2022 Mar 21;:
pubmed: 35313282
Am J Trop Med Hyg. 2016 Feb;94(2):428-36
pubmed: 26728766
BMC Public Health. 2020 Jun 1;20(1):831
pubmed: 32487209
Ann Behav Med. 2007 Jun;33(3):221-35
pubmed: 17600449
Clin Infect Dis. 2009 Nov 15;49(10):1473-9
pubmed: 19842974
J Epidemiol Community Health. 2013 Mar;67(3):245-9
pubmed: 23100381
Health Educ Behav. 2007 Oct;34(5):777-92
pubmed: 17200094
Clin Infect Dis. 2021 Nov 2;73(9):e2560-e2568
pubmed: 32761174
Am J Infect Control. 2014 Mar;42(3):305-10
pubmed: 24406254
Bull World Health Organ. 1981;59(2):263-8
pubmed: 7018729
BMC Res Notes. 2015 Oct 14;8:567
pubmed: 26467316
Am J Trop Med Hyg. 2014 Aug;91(2):415-23
pubmed: 24914003
Emerg Infect Dis. 2016 Feb;22(2):233-41
pubmed: 26811968
PLoS Negl Trop Dis. 2009;3(5):e436
pubmed: 19436726
Am J Trop Med Hyg. 2016 Dec 7;95(6):1292-1298
pubmed: 27799644
Am J Public Health. 1999 Mar;89(3):336-45
pubmed: 10076482

Auteurs

Lucien Bisimwa (L)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.
Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu B.P 265, Democratic Republic of the Congo.

Camille Williams (C)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.

Jean-Claude Bisimwa (JC)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.
Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu B.P 265, Democratic Republic of the Congo.

Presence Sanvura (P)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.
Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu B.P 265, Democratic Republic of the Congo.

Kelly Endres (K)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.

Elizabeth Thomas (E)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.

Jamie Perin (J)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.

Cirhuza Cikomola (C)

Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu B.P 265, Democratic Republic of the Congo.

Justin Bengehya (J)

Bureau de l'Information Sanitaire, Surveillance Epidémiologique et Recherche Scientifique Division Provinciale de la Santé/Sud Kivu, Ministère de la Santé Publique, Hygiène et Prévention, Bukavu B.P 265, Democratic Republic of the Congo.

Ghislain Maheshe (G)

Faculty of Medicine, Université Catholique de Bukavu, Bukavu B.P 265, Democratic Republic of the Congo.

Alain Mwishingo (A)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.
Center for Tropical Diseases & Global Health, Université Catholique de Bukavu, Bukavu B.P 265, Democratic Republic of the Congo.

Christine Marie George (CM)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205-2103, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH